2L9 Intrinsic Valuation and Fundamental Analysis - Blueprint Medicines Corp

B	Blueprint Medicines Corp F:2L9	US
	Pou Sheng International (Holdings) Ltd F:P5C	HK

Intrinsic Value

The intrinsic value for Blueprint Medicines Corp (2L9) under the Base Case is 72.01 EUR. Compared with the current market price of 110.05 EUR, the stock appears Overvalued by 35% .

Intrinsic value calculated using DCF

€72.01

Other reference points

Multiples estimate

€79.54

Do our valuations actually work? See backtest results .

2L9 Intrinsic Value

Overvaluation 35%

Intrinsic Value

Price €110.05

Loading...

What is Valuation History?

Track Buy Zone

20% below Intrinsic Value €57.6

Get notified when the price drops into your buy zone

Current Price €110.05

Intrinsic Value €72.01

Margin of Safety 20% €57.6

Or choose another margin of safety

0% below Intrinsic Value

10% below Intrinsic Value

30% below Intrinsic Value

40% below Intrinsic Value

50% below Intrinsic Value

Custom

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations

Let our AI break down the key assumptions behind the intrinsic value calculation for Blueprint Medicines Corp.

Explain Valuation